Rate the Article: An Observational Study of Seroprevalence of Hepatitis B, Hepatitis C and HIV (Human Immunodeficiency Virus) and Association of Risk Factors among Cataract Patients, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 3 | Views: 253 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Ophthalmology | India | Volume 10 Issue 11, November 2021 | Rating: 5.1 / 10


An Observational Study of Seroprevalence of Hepatitis B, Hepatitis C and HIV (Human Immunodeficiency Virus) and Association of Risk Factors among Cataract Patients

Harshita Khetan


Abstract: Aims: To study the seroprevalence of hepatitis B, hepatitis C and HIV (Human Immunodeficiency Virus) among patients of cataract surgery and to study the association of risk factors leading to hepatitis b, hepatitis C and HIV (Human Immunodeficiency Virus) among preoperative cataract patients. Methods: Preoperative cataract patients were selected for screening of viral markers. Local examination and systemic examination was done before enrolling the patients for the study. Results: The risk factor responsible for causing Hepatitis B and Hepatitis C were more common amongst patients who had history of blood transfusion (25.4% and 30.1% respectively), and patients who had received injection from unqualified practitioner(25.4% and 18.1% respectively) whereas the risk factor responsible for HIV (52.38%) was more with patients who had history of unprotected/ unnatural sex. Although history of previous surgery seems to be a risk factor but it statistically insignificant as it was also found in viral negative patients


Keywords: Seroprevalence, Hepatitis B, Hepatitis C, HIV, Human Immunodeficiency Virus, Cataract


Edition: Volume 10 Issue 11, November 2021,


Pages: 92 - 95



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top